Patent Assignment
Reel/Frame 066685/0660
Assignment of Assignor's Interest
Recorded: 2024-03-07
Pages: 6
Assignor
METRO BIOTECH NSW PTY LTD
Executed: 2024-03-06
Assignee
METRO INTERNATIONAL BIOTECH, LLC
100 BARBER AVENUE, WORCESTER, MASSACHUSETTS, 01606
Covered Properties
(3)
Targeting Nad+ to Treat Chemotherapy and Radiotherapy Induced Cognitive Impairment, Neuropathies and Inactivity
Patent:
10,603,334 →
Application:
15/570,210 →
Publication:
US 2018/0125871
PCT:
PCT/US2016/029765 ↗
Targeting Nad+ to Treat Chemotherapy and Radiotherapy Induced Cognitive Impairment, Neuropathies and Inactivity
Targeting Nad+ to Treat Chemotherapy and Radiotherapy Induced Cognitive Impairment, Neuropathies and Inactivity
Application:
62/153,876 →
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 18, 2015
From: SINCLAIR, DAVID A.; WU, LINDSAY
To: NEWSOUTH INNOVATIONS PTY LTD
Reel/Frame 037330/0891 →
Assignment of Assignor's Interest
Dec 20, 2017
From: WU, LINDSAY EDWARD; SINCLAIR, DAVID A.
To: NEWSOUTH INNOVATIONS PTY. LIMITED
Reel/Frame 044447/0180 →
Assignment of Assignor's Interest
Aug 9, 2018
From: SINCLAIR, DAVID A.; WU, LINDSAY E.
To: NEWSOUTH INNOVATIONS PTY LTD
Reel/Frame 046606/0027 →
Assignment of Assignor's Interest
May 12, 2022
From: SINCLAIR, DAVID A.; WU, LINDSAY EDWARD
To: NEWSOUTH INNOVATIONS PTY LTD
Reel/Frame 059986/0382 →
Assignment of Assignor's Interest
Mar 7, 2024
From: NEWSOUTH INNOVATIONS PTY LTD
To: METRO BIOTECH NSW PTY LTD
Reel/Frame 066685/0624 →